SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 3, 2003
EPOCH BIOSCIENCES, INC.
(Exact name of Registrant as specified in charter)
| | | | | |
Delaware
(State or other jurisdiction
of incorporation) | | 0-22170
(Commission
File Number) | | 91-1311592
(I.R.S. Employer
Identification No.) |
| | | |
21720 23rd Drive S.E., Suite 150, Bothell, Washington
(Address of principal executive offices) |
| 98021
(Zip Code) |
Registrant’s telephone number, including area code (425) 482-5555
(Former name or former address, if changed, since last report.)
Page 1 of 5 Pages
Exhibit Index is on Page 4
TABLE OF CONTENTS
Item 5. Other Events
On February 3, 2003, Epoch Biosciences, Inc. issued a press release announcing that The Nasdaq Stock Market, Inc. had approved Epoch’s request to list its common stock on the Nasdaq SmallCap Market. Epoch’s common stock will be transferred to the Nasdaq SmallCap Market at the opening of business on February 4, 2003. Epoch’s common stock will continue to trade under the symbol “EBIO.”
Item 7. Exhibits
| | | |
| Exhibit | | |
| Number | | |
| | |
| 99.1 | | Press Release dated February 3, 2003. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | |
| | | EPOCH BIOSCIENCES, INC. |
| | | | | |
| Date: February 3, 2003. | | By: | | /s/ Bert W. Hogue
Bert W. Hogue
Vice President and
Chief Financial Officer |
EXHIBIT INDEX
The following exhibits are attached hereto and incorporated herein by reference:
| | | | | | | |
| Exhibit | | | | Sequentially |
| Number | | | | Numbered Page |
| | | |
|
| 99.1 | | Press Release dated February 3, 2003. | | | 5 | |
